Adaptive Biotechnologies President and COO Julie Rubinstein Reports Disposal of $954,441.88 in Common Shares

Bitget2026/11/07 00:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares Nov. 4-6, 2026, according to a Form 4 filing.
Rubinstein exercised stock options for 35,643 common shares at $12.14 per share over the same period.
Following the transactions, she directly owned 377,802 common shares and held 58,990 stock options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780664-26-000051), on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adaptive Biotechnologies President and COO Julie Rubinstein Reports Disposal of $954,441.88 in Common Shares

You may also like

Crypto prices